Numeric Investors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Numeric Investors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$247K	Buy	+5,410	New	+$270K	﹤0.01%	1006
2016 Q4	–	Sell	-14,900	Closed	-$447K	–	1270
2016 Q3	$447K	Buy	+14,900	New	+$464K	﹤0.01%	816
2016 Q1	–	Sell	-12,300	Closed	-$541K	–	1203
2015 Q4	$541K	Buy	+12,300	New	+$610K	0.01%	709
2015 Q3	–	Sell	-5,000	Closed	-$267K	–	1247
2015 Q2	$267K	Buy	+5,000	New	+$265K	﹤0.01%	793

Other funds holding JUNO

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Numeric Investors's JUNO Position: Q4 2017 in Review

Numeric Investors opened a new position in Juno Therapeutics, Inc. (JUNO) in Q4 2017: 5,410 shares worth $247K. The stake represents ﹤0.01% of the portfolio and ranks #1006 among its holdings. This is a return to the name: Numeric Investors previously reported a position in JUNO as recently as Q3 2016.

Numeric Investors first reported a position in JUNO in Q2 2015 and has held it in 4 quarters since. The position peaked at $541K in Q4 2015. 237 funds tracked by Wall St. Rank hold JUNO as of Q4 2017.

Numeric Investors held 5,410 shares of Juno Therapeutics, Inc. worth $247K as of Q4 2017.
Juno Therapeutics, Inc. was a new Numeric Investors position in Q4 2017.
Juno Therapeutics, Inc. made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #1006 holding.
Numeric Investors first reported a position in Juno Therapeutics, Inc. in Q2 2015 and has held it in 4 quarters since.
Numeric Investors's Juno Therapeutics, Inc. position peaked at $541K in Q4 2015.
237 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.